310 results on '"Omalizumab -- Research"'
Search Results
2. Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
3. Study Findings from Bern Update Knowledge in Antibodies (A Comparison of Natural and Therapeutic Anti-IgE Antibodies)
4. Predicting the children who'll outgrow allergies
5. Study Findings from Medical University of Gdansk Advance Knowledge in Cutaneous Mastocytosis (Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease)
6. Study Findings on Bronchiectasis Are Outlined in Reports from Kuwait University (Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study)
7. New Biologics Findings from Brigham and Women's Hospital Reported (Temporal Variation In the Effectiveness of Biologics In Asthma: Effect Modification By Changing Patient Characteristics)
8. New Findings from Medical University of South Carolina Update Understanding of Drug Research (Reduced Sense of Smell In Patients With Severe Chronic Rhinosinusitis and Its Implications for Diagnosis and Management: a Narrative Review)
9. First Affiliated Hospital of Soochow University Researchers Publish New Studies and Findings in the Area of Urticaria (Case report: Exploration of abrocitinib in the treatment of refractory chronic spontaneous urticaria: a case series)
10. Data from Harvard T.H. Chan School of Public Health Advance Knowledge in Monoclonal Antibodies (Hla-dr+ Regulatory T Cells and Il-10 Are Associated With Success or Failure of Desensitization Outcomes)
11. Data on Urticaria Discussed by a Researcher at Dermatology Unit (Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience)
12. Reports on Biologics Findings from Virginia Commonwealth University Provide New Insights (Impact of Biologics On Surgery In Chronic Rhinosinusitis With Polyps and Allergic Fungal Sinusitis)
13. Reports on Food Allergies Findings from Dartmouth-Hitchcock Medical Center Provide New Insights (The Cost-effectiveness of Omalizumab for Treatment of Food Allergy)
14. Research on Biologics Reported by Researchers at Capital Medical University (The management of exercise-induced anaphylaxis in a Chinese child with biologics: a case report)
15. New Urticaria Study Findings Have Been Reported by Investigators at Chengdu University of Traditional Chinese Medicine (Temporal, Drug Dose, and Sample Size Trends In the Efficacy of Omalizumab for Chronic Spontaneous Urticaria: a Cumulative ...)
16. Research from University Clinic of Respiratory and Allergic Diseases Golnik in the Area of Urticaria Published (Autoimmune Mast Cell Activation Test as a Diagnostic Tool in Chronic Spontaneous Urticaria)
17. Reports Summarize Urticaria Study Results from Chiang Mai University (Cost and Cost-Effectiveness of the Management Strategies of Chronic Urticaria)
18. New Findings from University of Southampton Describe Advances in Asthma (Biomarker Predictors of Clinical Efficacy of the Anti-ige Biologic Omalizumab In Severe Asthma In Adults Results of the Somosa Study)
19. Reports Outline Asthma Study Findings from University Hospitals of North Midlands NHS Foundation Trust (Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial)
20. Studies from Memorial Sloan-Kettering Cancer Center Yield New Data on Urticaria (Omalizumab for Treatment of Anti-GD2 Antibody-Related Urticaria)
21. Findings in Urticaria Reported from Medical University of Silesia (Assessment of ELR, PLR, NLR and BLR Ratios during Omalizumab Treatment of Chronic Spontaneous Urticaria)
22. Researchers from Coimbra University Hospital Detail New Studies and Findings in the Area of Urticaria (Omalizumab and new therapeutic targets in chronic spontaneous urticaria)
23. Genentech Inc. Researchers Yield New Study Findings on Urticaria (Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?)
24. Data on Bullous Pemphigoid Reported by a Researcher at Istanbul University-Cerrahpasa (Omalizumab in the treatment of bullous pemphigoid: A single-center series of 15 cases)
25. Researchers at Wroclaw Medical University Have Published New Study Findings on Rhinitis (Biological Therapy, Therapeutic Approaches and Future Perspectives in the Treatment of Chronic Rhinitis)
26. Researchers from Brigham and Women's Hospital Provide Details of New Studies and Findings in the Area of Biologics (Smaller Differences In the Comparative Effectiveness of Biologics In Reducing Asthma-related Hospitalizations Compared With ...)
27. King's College Researcher Provides New Study Findings on Urticaria (PD04 Characterization of demographic, clinical and photobiological features of solar urticaria: a UK multicentre cross-sectional study)
28. New Bullous Pemphigoid Findings from University Hospital Caremeau Reported (Interest of Therapeutic Plasmapheresis In a Chronic Hemodialysis Patient With Severe Bullous Pemphigoid)
29. Research in the Area of Biologics Reported from Queen Mary University of London (Immunogenicity of biologics used in the treatment of asthma)
30. New Biologics Study Findings Have Been Published by a Researcher at Humanitas University (New evidence in food allergies treatment)
31. Studies from Dow University of Health Sciences in the Area of Food Allergies Described (Omalizumab for the reduction of allergic reactions to foods: a narrative review)
32. New Study Findings from I.M. Sechenov First Moscow State Medical University Illuminate Research in COVID-19 (Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations)
33. Zhejiang Chinese Medical University Reports Findings in Urticaria (Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta-analysis)
34. Stallergenes Greer Publishes in the Lancet Regional Health-Europe Landmark EfficAPSI Real-world Study Confirming Significant Benefit of Its Liquid Sublingual AIT on the Onset and Progression of Allergic Asthma
35. DRUG CUTS RISK OF ALLERGIC REACTIONS TO PEANUTS AND OTHER FOODS
36. Research Roundup: Post-COVID hangovers, ChatGPT's human-like behavior and more Login or create an account
37. New study finds simple jab 'can prevent severe allergic reactions'; Omalizumab appears able to provide relief from multiple food allergens at once
38. Study Results from Tongji University School of Medicine Broaden Understanding of Autoimmunity (Janus kinase inhibitors in autoimmune bullous diseases)
39. University of Western Australia Researchers Provide New Study Findings on Gene Therapy (Targeting IgE and Th2-Cytokines in Allergy: Brief Updates on Monoclonal Antibodies and Antibody Gene Therapy)
40. Treating CSU, Dupilumab Plus Antihistamines Superior to Antihistamines Alone: Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study
41. New Findings Reported from NorthShore University Health System Describe Advances in Urticaria (Do Regional Geography and Race Influence Management of Chronic Spontaneous Urticaria?)
42. DRUG LIMITS DANGEROUS REACTIONS TO ALLERGY-TRIGGERING FOODS, STANFORD MEDICINE-LED STUDY OF KIDS FINDS
43. OMALIZUMAB INCREASES THE REACTION THRESHOLD FOR PEANUT AND OTHER COMMON FOOD ALLERGIES
44. New Findings on Urticaria from University of Colorado Summarized (Total Ige As a Biomarker of Omalizumab Response In Chronic Spontaneous Urticaria: a Meta-analysis)
45. Reports Outline Asthma Study Findings from Brigham and Women's Hospital and Harvard Medical School (Ratio of plasma IL-13/TNF- and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or ...)
46. Charite - University Medicine Berlin Researcher Has Provided New Data on Biologics (Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps)
47. Study Findings on Urticaria Are Outlined in Reports from Tel Aviv University (Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels)
48. Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Researcher Updates Current Data on Bullous Pemphigoid (A Systematic Evaluation of Dupilumab for Bullous Pemphigoid Treatment)
49. University of Hong Kong Researchers Publish Findings in Urticaria (Disparities in chronic spontaneous urticaria: Eligibility for drug reimbursement associated with clinical outcomes)
50. New cause of asthma lung damage revealed
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.